|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, January 16, 2019 ) The study involved four major activities in estimating the current market size for synthetic stem cells. Exhaustive secondary research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. The top-down approach was employed to estimate the complete market size.
On the basis of region, the synthetic stem cell market is segmented as follows:
- North America
- Europe
- Asia Pacific
- RoW
Speak To analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=4959435
Geographical Analysis:
North America is estimated to account for the largest share of the market in 2023. This is majorly attributed to the rising research on stem cells in the region, coupled with public-private funding. The region is a global leader in the research on regenerative therapies such as stem cells and is backed by funding on advanced research infrastructure to commercialize novel regenerative therapies. Moreover, North America is the pioneer of synthetic stem cell technology and will be the early adopter of this technology in the coming years.
The research on cardiac synthetic stem cells is expected to enter the clinical phase in the coming 2-3 years, and the first commercial product would be cardiac synthetic stem cells in the next five years.
Key Market Players:
The technology is developed and patented by North Carolina State University (NCSU) (US) and Zhengzhou University (China).
Download PDF: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=4959435
MarketsandMarkets
Mr. Shelly Singh
1-888-600-6441
sales@marketsandmarkets.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
